136 related articles for article (PubMed ID: 15336984)
1. TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression.
Wissenbach U; Niemeyer B; Himmerkus N; Fixemer T; Bonkhoff H; Flockerzi V
Biochem Biophys Res Commun; 2004 Oct; 322(4):1359-63. PubMed ID: 15336984
[TBL] [Abstract][Full Text] [Related]
2. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.
Fixemer T; Wissenbach U; Flockerzi V; Bonkhoff H
Oncogene; 2003 Oct; 22(49):7858-61. PubMed ID: 14586412
[TBL] [Abstract][Full Text] [Related]
3. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways.
Lehen'kyi V; Flourakis M; Skryma R; Prevarskaya N
Oncogene; 2007 Nov; 26(52):7380-5. PubMed ID: 17533368
[TBL] [Abstract][Full Text] [Related]
4. TRPV6 potentiates calcium-dependent cell proliferation.
Schwarz EC; Wissenbach U; Niemeyer BA; Strauss B; Philipp SE; Flockerzi V; Hoth M
Cell Calcium; 2006 Feb; 39(2):163-73. PubMed ID: 16356545
[TBL] [Abstract][Full Text] [Related]
5. Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.
Lallet-Daher H; Roudbaraki M; Bavencoffe A; Mariot P; Gackière F; Bidaux G; Urbain R; Gosset P; Delcourt P; Fleurisse L; Slomianny C; Dewailly E; Mauroy B; Bonnal JL; Skryma R; Prevarskaya N
Oncogene; 2009 Apr; 28(15):1792-806. PubMed ID: 19270724
[TBL] [Abstract][Full Text] [Related]
6. TRPV6.
Wissenbach U; Niemeyer BA
Handb Exp Pharmacol; 2007; (179):221-34. PubMed ID: 17217060
[TBL] [Abstract][Full Text] [Related]
7. Rapid effects of 17beta-estradiol on epithelial TRPV6 Ca2+ channel in human T84 colonic cells.
Irnaten M; Blanchard-Gutton N; Harvey BJ
Cell Calcium; 2008 Nov; 44(5):441-52. PubMed ID: 18395250
[TBL] [Abstract][Full Text] [Related]
8. Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells.
Thebault S; Flourakis M; Vanoverberghe K; Vandermoere F; Roudbaraki M; Lehen'kyi V; Slomianny C; Beck B; Mariot P; Bonnal JL; Mauroy B; Shuba Y; Capiod T; Skryma R; Prevarskaya N
Cancer Res; 2006 Feb; 66(4):2038-47. PubMed ID: 16489003
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal positive regulation between TRPV6 and NUMB in PTEN-deficient prostate cancer cells.
Kim SY; Hong C; Wie J; Kim E; Kim BJ; Ha K; Cho NH; Kim IG; Jeon JH; So I
Biochem Biophys Res Commun; 2014 Apr; 447(1):192-6. PubMed ID: 24704446
[TBL] [Abstract][Full Text] [Related]
10. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
Dalrymple S; Antony L; Xu Y; Uzgare AR; Arnold JT; Savaugeot J; Sokoll LJ; De Marzo AM; Isaacs JT
Cancer Res; 2005 Oct; 65(20):9269-79. PubMed ID: 16230388
[TBL] [Abstract][Full Text] [Related]
11. TRP proteins and cancer.
Bödding M
Cell Signal; 2007 Mar; 19(3):617-24. PubMed ID: 17029734
[TBL] [Abstract][Full Text] [Related]
12. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
[TBL] [Abstract][Full Text] [Related]
13. RNA interference mediated suppression of TRPV6 inhibits the progression of prostate cancer
Kim DY; Kim SH; Yang EK
Investig Clin Urol; 2021 Jul; 62(4):447-454. PubMed ID: 34085788
[TBL] [Abstract][Full Text] [Related]
14. [TRPV5 and TRPV6 calcium channels in human T cells].
Vasil'eva IO; Neguliaev IuA; Marakhova II; Semenova SB
Tsitologiia; 2008; 50(11):953-7. PubMed ID: 19140341
[TBL] [Abstract][Full Text] [Related]
15. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
[TBL] [Abstract][Full Text] [Related]
16. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
17. The beta-glucuronidase klotho exclusively activates the epithelial Ca2+ channels TRPV5 and TRPV6.
Lu P; Boros S; Chang Q; Bindels RJ; Hoenderop JG
Nephrol Dial Transplant; 2008 Nov; 23(11):3397-402. PubMed ID: 18495742
[TBL] [Abstract][Full Text] [Related]
18. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of androgen action in prostate cancer.
Dehm SM; Tindall DJ
J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
[TBL] [Abstract][Full Text] [Related]
20. TREK-1 is a novel molecular target in prostate cancer.
Voloshyna I; Besana A; Castillo M; Matos T; Weinstein IB; Mansukhani M; Robinson RB; Cordon-Cardo C; Feinmark SJ
Cancer Res; 2008 Feb; 68(4):1197-203. PubMed ID: 18281496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
